Global Alzheimer's Disease Drugs Industry (2020 to 2027) - Market Trajectory & Analytics
Dublin, March 15, 2021 (GLOBE NEWSWIRE) -- The "Alzheimer's Disease Drugs - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Amid the COVID-19 crisis, the global market for Alzheimers Disease Drugs estimated at US$ 5.9 Billion in the year 2020, is projected to reach a revised size of US$ 9.4 Billion by 2027, growing at a CAGR of 6.8% over the analysis period 2020-2027.
Cholinergic, one of the segments analyzed in the report, is projected to record a 7% CAGR and reach US$ 4.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Memantine segment is readjusted to a revised 7.2% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at 10.3% CAGR
The Alzheimers Disease Drugs market in the U.S. is estimated at US$ 1.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$ 2 Billion by the year 2027 trailing a CAGR of 10.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.
Combined Drugs Segment to Record 5.7% CAGR
In the global Combined Drugs segment, USA, Canada, Japan, China and Europe will drive the 5.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$ 1.1 Billion in the year 2020 will reach a projected size of US$ 1.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$ 1.3 Billion by the year 2027, while Latin America will expand at a 6.9% CAGR through the analysis period.
Select Competitors (Total 43 Featured):
Daiichi Sankyo Company Limited
Eisai Co Ltd
H Lundbeck A/S
Johnson & Johnson
Merz Holding GmbH & Co KG
Key Topics Covered:
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Alzheimer's Disease Drugs Competitor Market Share Scenario Worldwide (in %): 2020E
Global Competitor Market Shares by Segment
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Total Companies Profiled: 43
For more information about this report visit https://www.researchandmarkets.com/r/pplix4
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900